No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
JonesTrading Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $34
Cullinan Oncology Coverage Assumed by Morgan Stanley at Overweight
Morgan Stanley Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Maintains Target Price $35
Express News | Cullinan Therapeutics : Morgan Stanley Cuts Target Price to $35.00 From $38.00
Morgan Stanley Initiates Cullinan Therapeutics(CGEM.US) With Buy Rating, Announces Target Price $35
Stifel Maintains Cullinan Therapeutics(CGEM.US) With Buy Rating, Cuts Target Price to $30